Exponent Q1 Revenues Rise 10% to $151.8M, EBITDA Margin at 28.4%
Exponent's Q1 2026 revenue before reimbursements rose 10% to $151.8M, driving net income of $29.6M ($0.59/share), up from $26.7M in Q1 2025. The company boosted EBITDA margin to 28.4% and approved an additional $50M stock repurchase, alongside a $0.31 quarterly dividend.
1. First Quarter Financial Results
Exponent reported total Q1 revenue of $166.3M, up 14%, and revenue before reimbursements of $151.8M, up 10% year-over-year. Net income rose to $29.6M ($0.59 per diluted share) from $26.7M ($0.52), while EBITDA increased to $43.1M, or 28.4% of net revenues, driven by AI-enabled user research in consumer electronics, risk management for utilities, and reactive failure analyses in construction, energy and medical devices.
2. Capital Return Initiatives
During the quarter Exponent paid $16.6M in dividends and repurchased $78.8M of common stock, ending with $118.6M in cash. The board approved a $50M increase to the existing repurchase program—on top of $17.7M available as of April 3—and declared a $0.31 quarterly dividend payable June 18, 2026.
3. Outlook and Strategy
For Q2, Exponent anticipates high-single-digit growth in revenue before reimbursements and an EBITDA margin of 27.0%–27.8%, while maintaining full-year guidance of similar growth and 27.6%–28.1% margins. The company cited 5% headcount growth, 76% utilization and strong rate realization, and highlighted recent leadership appointments of John Pye and Eric Anderson to support strategic execution.